These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2386659)

  • 1. 31P NMR study of cisplatin- and doxorubicin-induced changes in tumour metabolism in rats with a cisplatin-sensitive or -resistant immunocytoma.
    Sijens PE; van Echteld CJ; van Rijssel RH; Lagendijk JJ; Neijt JP; de Jong WH; van der Minnen AC; de Groot G; Seijkens D
    NMR Biomed; 1990 Jun; 3(3):124-31. PubMed ID: 2386659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison in three sublines with increasing resistance.
    Tausch-Treml R; Köpf-Maier P; Baumgart F; Gewiese B; Ziessow D; Scherer H; Wolf KJ
    Br J Cancer; 1991 Sep; 64(3):485-93. PubMed ID: 1911189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
    Lyng H; Olsen DR; Southon TE; Rofstad EK
    Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.
    Ceckler TL; Gibson SL; Kennedy SD; Hill R; Bryant RG
    Br J Cancer; 1991 Jun; 63(6):916-22. PubMed ID: 1829953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
    Lemaire LP; McSheehy PM; Griffiths JR
    Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.
    Twelves CJ; Porter DA; Lowry M; Dobbs NA; Graves PE; Smith MA; Rubens RD; Richards MA
    Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumor growth and treatment with cisplatin on the tumor phosphorus metabolism, histology and cytokinetics.
    Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
    NMR Biomed; 1992; 5(3):127-36. PubMed ID: 1642969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumor.
    Storm G; Van Gessel HJ; Steerenberg PA; Speth PA; Roerdink FH; Regts J; Van Veen M; De Jong WH
    Cancer Drug Deliv; 1987; 4(2):89-104. PubMed ID: 3427554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas.
    Evelhoch JL; Keller NA; Corbett TH
    Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia.
    Vaupel P; Okunieff P; Neuringer LJ
    Int J Hyperthermia; 1990; 6(1):15-31. PubMed ID: 2299228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
    Winter PM; Poptani H; Bansal N
    Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts.
    Vendrik CP; Fichtinger-Schepman AM; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; de Groot G; Berends GF; Steerenberg PA
    Cancer Chemother Pharmacol; 1997; 39(6):479-85. PubMed ID: 9118458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of artefacts in localized and non-localized 31P MRS studies of phosphate metabolites and pH in rat tumours.
    Howe FA; Stubbs M; Rodrigues LM; Griffiths JR
    NMR Biomed; 1993; 6(1):43-52. PubMed ID: 8457426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude mice.
    Ballinger JR; Kang H; Sweeney CA; Scott JD; Croker BP; Scott KN
    Magn Reson Imaging; 1995; 13(6):877-83. PubMed ID: 8544659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin.
    Steerenberg PA; Vendrik CP; de Jong WH; de Groot G; Fichtinger-Schepman AM; Scheefhals AP; Schornagel JH
    Cancer Chemother Pharmacol; 1988; 22(1):51-7. PubMed ID: 3293840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP; de Jong WH; Van der Minnen AC; Fichtinger-Schepman AM; Steerenberg PA; Schornagel JH
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth studies of subcutaneous rat tumours: comparison of 31P-NMR spectroscopy, acid extracts and histology.
    Stubbs M; Rodrigues LM; Griffiths JR
    Br J Cancer; 1989 Nov; 60(5):701-7. PubMed ID: 2803946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status.
    Okunieff PG; Koutcher JA; Gerweck L; McFarland E; Hitzig B; Urano M; Brady T; Neuringer L; Suit HD
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):793-9. PubMed ID: 3710861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
    van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
    Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.